Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 1 hour 4 min ago

Gold And Its Miners: The Structural Bull Market Isn't Over

Mon, 02/23/2026 - 22:09

Dover: Trading At A Discount To Industrial - Reiterate A Buy

Mon, 02/23/2026 - 22:09

Fidelity Total Bond Fund Q4 2025 Commentary

Mon, 02/23/2026 - 22:00

Myriad Genetics outlines $860M–$880M revenue target for 2026 while advancing cancer care continuum strategy

Mon, 02/23/2026 - 21:55

Electromed: Some Short Term Gain But I Fear Long Term Pain

Mon, 02/23/2026 - 21:35

Assessing Newmont Corporation's Gold Bet - Lower Risk, Limited Asymmetry

Mon, 02/23/2026 - 21:35

Adobe Looks Like A Value Trap

Mon, 02/23/2026 - 21:30

FPA Short Duration Government ETF Q4 2025 Commentary

Mon, 02/23/2026 - 21:25

Zscaler Scales Zero Trust And AI Agent Security

Mon, 02/23/2026 - 21:23

Nestlé: Strategic Reset Underway, Recall Noise But Volume Momentum Emerging

Mon, 02/23/2026 - 21:22

BWXT outlines $3.75B 2026 revenue target while expanding commercial nuclear and medical growth

Mon, 02/23/2026 - 21:15

Coronado targets $300M annual margin expansion in 2026 through expansion projects and cost discipline

Mon, 02/23/2026 - 21:15

Software Volatility: Separating Noise From Signal

Mon, 02/23/2026 - 21:15

Iamgold: Strong Growth, Low Valuation, But Lofty Technical Stock Levels

Mon, 02/23/2026 - 20:35

Hims & Hers projects $2.7B–$2.9B revenue in 2026 while accelerating global expansion and new specialty launches

Mon, 02/23/2026 - 20:25

John Hancock 2060 Lifetime Blend Portfolio Target-Date Fund Q4 2025 Commentary

Mon, 02/23/2026 - 20:20

Allison outlines $5.575B–$5.925B 2026 sales target following Dana Off-Highway acquisition integration

Mon, 02/23/2026 - 20:15

Tarsus Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation

Mon, 02/23/2026 - 20:01

Summit Therapeutics Inc. 2025 Q4 - Results - Earnings Call Presentation

Mon, 02/23/2026 - 20:01

Sprouts Farmers Market: Buy The Dip

Mon, 02/23/2026 - 19:38

Pages